Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2015 | 07-2015 | 04-2015 | 01-2015 | 10-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,340,000 | 820,000 | 2,675,000 | 2,676,000 | 1,699,000 |
| Depreciation Amortization | 1,412,000 | 708,000 | 1,382,000 | 698,000 | 423,000 |
| Income taxes - deferred | -274,000 | -159,000 | -926,000 | -20,000 | -61,000 |
| Accounts receivable | -1,000 | 279,000 | -413,000 | -60,000 | -64,000 |
| Other Working Capital | -623,000 | -760,000 | 797,000 | 396,000 | -135,000 |
| Other Operating Activity | 241,000 | -72,000 | 1,387,000 | -700,000 | -639,000 |
| Operating Cash Flow | $2,095,000 | $816,000 | $4,902,000 | $2,990,000 | $1,223,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -618,000 | -585,000 | -1,692,000 | -976,000 | -359,000 |
| PPE Investments | -446,000 | -224,000 | -571,000 | -316,000 | -210,000 |
| Net Acquisitions | -997,000 | -179,000 | -14,884,000 | -611,000 | -578,000 |
| Other Investing Activity | -13,000 | 2,000 | 89,000 | 60,000 | -6,000 |
| Investing Cash Flow | $-2,074,000 | $-986,000 | $-17,058,000 | $-1,843,000 | $-1,153,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,325,000 | 429,000 | 149,000 | 157,000 | 1,761,000 |
| Debt Issued | 0 | N/A | 19,942,000 | 16,918,000 | N/A |
| Debt Repayment | -1,608,000 | -1,004,000 | -1,268,000 | -13,000 | -7,000 |
| Common Stock Issued | 263,000 | 98,000 | 649,000 | 477,000 | 312,000 |
| Common Stock Repurchased | -1,460,000 | -750,000 | -1,920,000 | -1,620,000 | -1,620,000 |
| Dividend Paid | -1,075,000 | -538,000 | -1,337,000 | -902,000 | -602,000 |
| Other Financing Activity | 30,000 | 21,000 | -266,000 | -219,000 | 29,000 |
| Financing Cash Flow | $-2,525,000 | $-1,744,000 | $15,949,000 | $14,798,000 | $-127,000 |
| Exchange Rate Effect | 39,000 | 50,000 | -353,000 | -117,000 | -59,000 |
| Beginning Cash Position | 4,843,000 | 4,843,000 | 1,403,000 | 1,403,000 | 1,403,000 |
| End Cash Position | 2,378,000 | 2,979,000 | 4,843,000 | 17,231,000 | 1,287,000 |
| Net Cash Flow | $-2,465,000 | $-1,864,000 | $3,440,000 | $15,828,000 | $-116,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,095,000 | 816,000 | 4,902,000 | 2,990,000 | 1,223,000 |
| Capital Expenditure | -446,000 | -224,000 | -571,000 | -316,000 | -210,000 |
| Free Cash Flow | 1,649,000 | 592,000 | 4,331,000 | 2,674,000 | 1,013,000 |